Zoetis ZTS
NYSE ZTS
$73.04 +0.04 (+0.05%)
As of: Sep 17, 2026 · 3:59 PM EDT

Zoetis (ZTS) Acquisitions (2015 - 2022)

Zoetis' (ZTS) quarterly Acquisitions came in at $215.0 million in Q3 2022, down 88.59% quarter-over-quarter from $1.9 billion in Q3 2018.

Analysis

Zoetis (ZTS) Acquisitions (2015 - 2022) Analysis & Trends

Zoetis (ZTS) has reported Acquisitions for 5 consecutive years, with $215.0 million the latest figure, recorded in Q3 2022.

  • On a quarterly basis, Acquisitions changed N/A year-over-year to $215.0 million in Q3 2022; TTM through Sep 2022 was $215.0 million, a N/A change from a year earlier, with the FY2018 full-year figure at $1.9 billion, changed N/A from the prior year.
  • Acquisitions was $215.0 million for Q3 2022 at Zoetis, down from $1.9 billion in the prior quarter.
  • Over five years, Acquisitions peaked at $1.9 billion in Q3 2018 and troughed at $215.0 million in Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Idexx Laboratories 40.57 Bn 40.38 Bn 779.09 Mn -
2 Zoetis 30.57 Bn 28.90 Bn 1.05 Bn -
3 Elanco Animal Health 11.47 Bn 10.94 Bn 798.00 Mn -
4 Phibro Animal Health 1.43 Bn 1.35 Bn 134.40 Mn -
5 Immucell 87.38 Mn 78.52 Mn 2.44 Mn -
6 Zhengye Biotechnology Holding 64.40 Mn 57.30 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 215.00 Mn
Sep 30, 2018 1.88 Bn
Oct 1, 2017 -3.00 Mn
Apr 2, 2017 3.00 Mn
Oct 2, 2016 68.00 Mn
Jul 3, 2016 8.00 Mn
Apr 3, 2016 12.00 Mn
Dec 31, 2015 654.00 Mn
Jun 28, 2015 -1.00 Mn
Mar 29, 2015 230.00 Mn